Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S12-S18 , March 2004

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was sponsored by an unrestricted educational grant from Allergan, Inc., Irvine, CA. The authors have no proprietary interest in bimatoprost or Allergan, Inc.

PII: S0039-6257(03)00190-5

doi: 10.1016/j.survophthal.2003.12.015

Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S12-S18 , March 2004

Article Tools

* Image Usage & Resolution